Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Oct 20;173(2):301–311. doi: 10.1007/s10549-018-5007-4

Table 2:

Predictors of BCT (cT3 patients)

OR 95% CI p-value Overall Significance
Age <0.001
≤45 0.928 0.760 1.133 0.462
46 – 55 1.145 0.954 1.376 0.147
56 – 65 1.211 1.014 1.447 0.035
>65 Referent
Race <0.001
White Referent
Black 1.471 1.310 1.652 <0.001
Unknown 0.766 0.616 0.953 0.017
Hispanic 0.297
No Referent
Yes 1.077 0.897 1.293 0.426
Unknown 1.140 0.952 1.365 0.155
Charlson Comorbidity Score 0.051
0 Referent
1 0.836 0.716 0.975 0.022
2 1.049 0.770 1.428 0.764
Insurance 0.060
Private Insurance Referent
Medicaid 1.086 0.944 1.250 0.249
Medicare 0.948 0.798 1.126 0.544
Not Insured 1.023 0.813 1.288 0.844
Other 1.052 0.694 1.593 0.813
Unknown 1.762 1.272 2.440 0.001
Educationa 0.318
21% or more Referent
13% - 20.9% 1.139 0.983 1.319 0.084
7% - 12.9% 1.153 0.972 1.369 0.103
Less than 7% 1.063 0.872 1.296 0.547
Missing 1.912 0.055 66.780 0.721
Income 0.755
< $38,000 Referent
$38,000 - $47,999 0.907 0.783 1.050 0.190
$48,000 - $62,999 0.921 0.786 1.078 0.306
$63,000 + 0.896 0.740 1.084 0.259
Missing 0.706 0.026 19.254 0.836
Urban settingb 0.330
Large Metropolitan Referent
Small metropolitan 0.912 0.805 1.033 0.148
Suburban 0.832 0.677 1.022 0.079
Rural 0.991 0.736 1.335 0.955
Unknown 0.964 0.719 1.291 0.804
Distance to reporting facility (miles)c 0.236
≤10 Referent
11 – 20 0.944 0.848 1.050 0.288
21 – 50 1.108 0.964 1.274 0.148
>50 0.952 0.750 1.209 0.688
Unknown 0.857 0.226 3.242 0.820
Geographic locationd <0.001
New England Referent
Middle Atlantic 0.816 0.639 1.043 0.105
South Atlantic 0.778 0.619 0.978 0.032
East North Central 0.728 0.566 0.937 0.008
East South Central 0.558 0.413 0.755 0.000
West North Central 0.539 0.399 0.729 <0.001
West South Central 0.757 0.561 1.023 0.070
Mountain 0.641 0.4773 0.869 0.004
Pacific 0.925 0.724 1.183 0.536
Facility Typee 0.005
Community Program Referent
Comprehensive Community 0.797 0.676 0.939 0.007
Academic/Research 0.963 0.801 1.158 0.687
Other/Missing 0.911 0.704 1.179 0.478
Year of diagnosis 0.951 0.932 0.970 <0.001 <0.001
Cancer Sequencef <0.001
First Referent
2+ 0.715 0.600 0.852 0.001
Tumor size <0.001
5.1 to 7 cm Referent
7.1 to 10 cm 0.576 0.521 0.637 <0.001
>10 cm 0.457 0.367 0.568 <0.001
No. nodes examined 0.948 0.941 0.975 <0.001 <0.001
No. nodes positive 0.928 0.914 0.943 <0.001 <0.001
Grade <0.001
1 Referent
2 1.123 0.930 1.356 0.252
3 1.542 1.275 1.866 <0.001
Undifferentiated 1.250 0.790 1.979 0.355
Unknown 1.416 1.114 1.801 0.005
Histology <0.001
Ductal Referent
Lobular 0.604 0.524 0.696 <0.001
Other 1.264 1.056 1.513 0.011
Chemotherapy <0.001
Adjuvant Referent
Neoadjuvant 1.687 1.499 1.898 <0.001
None 1.533 1.283 1.832 <0.001
Unknown 1.841 0.969 3.499 0.062
Radiotherapy <0.001
 Administered Referent
 Not administered 0.259 0.228 0.294 <0.001

Abbreviations: BCT, breast conservation therapy; cT3, clinical T3 patients

a

Education represents the percentage of individuals within a ZIP code from census data having <12 years of education.

b

Setting definitions: Large metropolitan indicates counties of metropolitan areas of >1,000,000; Small metropolitan, counties in metropolitan areas of <250,000 to 1,000,000; Suburban, urban population of >20,000 adjacent to a metropolitan area or 2500 to 19,999 adjacent to a metropolitan area; rural, completely rural or <2500 or >20,000 urban population nonadjacent to a metropolitan area.

c

Miles between patient’s residence and the hospital that reported the case

d

Region groupings: New England (CT, MA, ME, NH, RI, VT), Middle Atlantic (NJ, NY, PA), South Atlantic (DC, DE, FL, GA, MD, NC, SC, VA, WV), East North Central (IL, IN, MI, OH, WI), East South Central (AL, KY, MS, TN), West North Central (IA, KS, MN, MO, ND, NE, SD), West South Central (AR, LA, OK, TX), Mountain (AZ, CO, ID, MT, NM, NV, UT, WY), Pacific (AK, CA, HI, OR, WA).

e

Community Cancer program: >100 but <500 newly diagnosed cancer cases each year; Comprehensive community cancer program: 500 or more new cases for three consecutive years; Academic/Research program: participates in postgraduate medical education in at least four program areas, and >500 newly diagnosed cancer cases each year.

f

The number of the cancer that the breast cancer represents, among cancers of any type, if they had >1 cancer of any type during their lifetime.